Dr. Emad A. Elquza

"Dr. Lauren C. Pinter-Brown is a board-certified, fellowship-trained UCI hematologist-oncologist who specializes in the diagnosis and treatment of patients with lymphomas.A nationally recognized expert, Pinter-Brown has a longstanding interest in malignant lymphoma, with a particular focus on T-cell and skin lymphomas. Her clinical interests also include antiphospholipid, B-cell lymphoma, Hodgkin's lymphoma, mycosis fungoides, non-Hodgkins lymphoma, stem-cell transplant and Waldenstrom's disease.She her medical degree at the David Geffen School of Medicine at UCLA Medical School, followed by an internship and residency in internal medicine at Harbor-UCLA Medical Center. She completed a fellowship in hematology and oncology at the Keck School of Medicine at USC.A prolific clinical investigator, Pinter-Brown has made important contributions to several clinical trials that led to approval of new drugs for the treatment of T-cell lymphoma. Her research focus is on optimizing treatment options for patients with lymphoma, especially cutaneous and T-cell lymphomas. Her primary goal is to care for patients through diagnosis, treatment and beyond and to ensure that they are able ""to live their best life.""". Dr. Pinter-Brown is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), and Bone Marrow Transplant. Dr. Pinter-Brown is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine - Internal Medicine.

Dr. Warren A. Chow is a board-certified UCI Health oncologist who specializes in melanoma and sarcomas. He serves as associate director for clinical services at the UCI Health Chao Family Comprehensive Cancer Center.He received his medical degree from Chicago Medical School at Rosalind Franklin University of Medicine and Science in North Chicago, Ill. He completed an internship and residency in internal medicine at Cedars-Sinai Medical Center in Los Angeles. Next he received fellowship training in medical oncology, hematology and bone marrow transplantation at the City of Hope in Duarte, Calif., where he served nearly 30 years as a clinician and researcher conducting bench-to-bedside studies in both bone and soft-tissue sarcomas.The recipient of numerous research grants from the National Cancer Institute, the U.S. Food and Drug Administration, the Melanoma Research Foundation and many others, Chow has been the principal investigator on more than three dozen clinical trials. He is the author of more than 80 publications and four book chapters, and he serves on the editorial boards of the journalsPLOS ONE,F1000 ResearchandScientific Reports (Nature). Dr. Chow is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Synovial Sarcoma, Adult Soft Tissue Sarcoma, Liposarcoma, and Chondrosarcoma. Dr. Chow is board certified in American Board Of Internal Medicine - Medical Oncology and American Board Of Internal Medicine - Internal Medicine.

Dr. Stefan O. Ciurea is a UCI Health hematologist and director of the Hematopoietic Stem Cell Transplantation and Cellular Therapy Program at the Chao Family Comprehensive Cancer Center.Ciurea earned his medical degree at Grigore T. Popa University of Medicine and Pharmaceuticals in Iasi, Romania. He completed an internal medicine residency at UPMC Pinnacle Harrisburg in Harrisburg, Pa. He then completed a fellowship in hematology-oncology at University of Illinois at Chicago College of Medicine, followed by a fellowship in stem cell transplantation and cellular therapy at the University of Texas MD Anderson Cancer Center in Houston.Before joining the Chao Family Comprehensive Cancer Center to lead its program in hematopoietic stem cell transplantation and cellular therapy, Ciurea served for more than a decade on the faculty of the MD Anderson Cancer Center’s Department of Stem Cell Transplantation and Cellular Therapy.Ciurea is the author of more than 150 peer-reviewed publications and more than 10 book chapters. He also has served as principal investigator on multiple clinical trials, including investigator-initiated trials. He has been invited to speak at more than 50 meetings and conferences around the world, including as keynote speaker. Dr. Ciurea is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Ciurea is board certified in American Board Of Internal Medicine - Hematology.